by Mark Curtis | Apr 7, 2015
. Welcome to your Update from the Clinic for the month of March. Investors weren’t so keen on Neuralstem’s topline results in amyotropic lateral sclerosis (ALS). NeoStem’s follow-up data from its PreSERVE study in acute myocardial infarction (AMI) was somewhat...
by Stacey Johnson | Apr 3, 2015
. Last month (March 13), StemCellTalks held a symposium on diabetes and stem cell tourism to educate Toronto high school students about the field. (These events happen across Canada.) The morning session began with Dr. Elia Piccinini (University of Toronto) giving an...
by Stacey Johnson | Mar 31, 2015
. In May 2012, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM) launched Signals Blog, an evolution of SCN’s popular Stem Cell Network Blog and the brainchild of Lisa Willemse, Director of Communications at SCN. Beyond...
by Lisa Willemse | Mar 27, 2015
> This is my final post as co-editor of Signals, and in sitting down to draft it, I found myself struggling to find words. How do you sum up six years of blogging? Quite simply, you don’t. However, as this also marks the end of the Stem Cell Network’s involvement...
by Mark Curtis | Mar 25, 2015
. Welcome to your Update from the Clinic for the month of February. Northwest Biotherapeutics received approval from Health Canada to proceed with its ongoing Phase 3 clinical study in Glioblastoma multiforme at clinical sites in Quebec. Sangamo and bluebird bio both...
by David Kent | Mar 24, 2015
> At one of my very first Canadian Stem Cell Network Annual General Meetings, when I was just a couple of years into my stem cell biology training, I remember sitting down just after lunch when a jovial Italian man sauntered up to the stage and apologized to the...
by Sara M. Nolte | Mar 23, 2015
> I have previously written about the phrase “cancer stem cell,” and how it can be misleading for researchers and the public alike. As scientists, we go through great pains to be specific in our use of ‘cancer stem cell’ (CSC), referring to a cell that possesses...
by Stacey Johnson | Mar 20, 2015
. American media and telecom billionaire John Malone, along with his horse-breeding wife Leslie, have generously donated U.S. $42.5 million to Colorado State University to launch the CSU Institute for Biologic Translational Therapies to develop regenerative medicine...
by David Kent | Mar 18, 2015
Earlier this month, Harvard Medical School researchers published a brief report in Cell Stem Cell, which showed in non-human primates – in this case monkeys – that Parkinson’s disease symptoms could be alleviated using stem cell therapy. Using induced pluripotent stem...
by Lisa Willemse | Mar 17, 2015
> Many of us only become acutely aware of our brain when it’s not working quite right. Like, say, if we have a migraine, or are diagnosed with a mental illness. Or we fall on the ice and give ourself a concussion that affects our vision, motor skills and...
Comments